Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Common Stock, par value $0.001 per share · CUSIP: 00166B105

Event date: 2025-10-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Millennium Management LLC

    Shares: 2,707,151.00 · Class: 5.1%

  • Millennium Group Management LLC

    Shares: 2,707,151.00 · Class: 5.1%

  • Israel A. Englander

    Shares: 2,707,151.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-097929
Form type
SCHEDULE 13G
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
Oct 08, 2025
Reporting period
Oct 02, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub